Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 407, 285 (21 September 2000) | doi:10.1038/35030194
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
- More Challenges
- Powered by:
nature jobs
Copy Editor
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Postdoctoral Fellowship in Genetic Epidemiology
- McGill University
- Montreal, Quebec, Canada
Allowing gene patents could be an expensive mistake for the US
Hartmut Michel1
- Max Planck Institut of Biophysics,
Heinrich-Hoffmann-Stra
e 7, 60528 Frankfurt
am Main, Germany
Sir — In the discussion of gene patents1, it is generally overlooked that these primarily aim at the encoded protein and not the gene. The discoverers try to patent the use of the 'gene product' either as a therapeutic protein, or as an intervention point ('drug target') to treat a disease.
To read this story in full you will need to login or make a payment (see right).
